Viewpoint: Why it’s harmful for regulators and consumers to trust cancer designations by the UN sub-agency IARC

image

IARC‘s hazard identification scheme, which assesses the carcinogenic potential of a chemical in a simple binary manner, is now obsolete. Since it was set in the early 1970s, the scheme has basically remained unchanged and has not reached the level of regulatory science of the 21st century. Whether to reform or abolish it, the world’s scientific, regulatory, and political circles are faced with a decision.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

Of the nearly 1,000 chemicals investigated in the history of IARC’s monograph program, only one was classified as “probably not carcinogenic.” For almost all chemicals, there is evidence that they are carcinogenic, and the process of concluding that they should be treated as such, or that they are “classifiable” (the available evidence cannot draw conclusions), is nearly worthless information for public health professionals.

However, IARC’s process is hazard-based, so if a substance has the potential to cause carcinogenicity, it will try to “label” it as carcinogenic, regardless of the circumstances. The premise itself is flawed. This has created a useless and even absurd mechanism to put chemicals in the same group with orders of magnitude different amounts that are likely to cause cancer.

[Editor’s note: This article has been translated from Japanese and edited for clarity.]

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
skin microbiome x final

Infographic: Could gut bacteria help us diagnose and treat diseases? This is on the horizon thanks to CRISPR gene editing

Humans are never alone. Even in a room devoid of other people, they are always in the company of billions ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.